Skip to content
Snippets Groups Projects
Commit f79e7086 authored by HauErn Lien's avatar HauErn Lien
Browse files

Update file hardware.html

parent 93aabc65
No related branches found
No related tags found
No related merge requests found
Pipeline #524541 passed
......@@ -113,9 +113,9 @@
<p style="text-indent: 20px;">The concept of our user interface was inspired by a productive discussion during one of our patient interviews with Sara Levitt, who proposed the idea of using an application to monitor medication dosages. This suggestion sparked a brainstorming session on how the user interface could enhance the patient experience. We identified several key functionalities designed to simplify patient management of their treatment regimen, including: </p>
<ul>
<li><b>Suggested Dosage</b>: Personalized dosage recommendations based on individual treatment needs.</li>
<li>Current Concentration: Real-time display of the muscone concentration, ensuring users are informed at all times.</li>
<li>Timer: A built-in timer feature to remind patients of scheduled doses, promoting adherence to their treatment plan.</li>
<li>Online Store: Direct access to an online store for easy replenishment of medication, facilitating a seamless user experience.</li>
<li><b>Current Concentration</b> Real-time display of the muscone concentration, ensuring users are informed at all times.</li>
<li><b>Timer</b>: A built-in timer feature to remind patients of scheduled doses, promoting adherence to their treatment plan.</li>
<li><b>Online Store</b> Direct access to an online store for easy replenishment of medication, facilitating a seamless user experience.</li>
</ul>
<p style="text-indent: 20px;">Further investigation and background research are required for continued development, and more clinical experiments are needed to support the project. The user interface will be implemented upon the project's completion.</p>
<div class="image-container" style="display: flex; flex-direction: column; align-items: center;">
......
0% Loading or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment